DNAJC5 and malaria: We previously showed that a bacteriophage Qß-based virus-like particle (VLP) vaccine that multivalently displays a peptide representing the epitope of the CIS43 mAb, which is located at the junction between the N-terminal region of CSP and the CR5, could elicit extremely durable and high-titer anti-CSP antibody responses and reduce parasite liver burden in a mouse malaria challenge model, but did not prevent blood-stage parasitemia10.